Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

NCT01167725 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: cetuximab
DRUG: FOLFIRI regimen
DRUG: FOLFOX regimen
DRUG: capecitabine
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: mitomycin C
DRUG: oxaliplatin
PROCEDURE: therapeutic conventional surgery

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]